Inogen Stock News

Inogen (INGN) saw growth in revenues within its Rental segment in Q2.

Joining me from Inogen is CEO, Scott Wilkinson and CFO and Co-Founder Ali Bauerlein. Earlier today, Inogen released financial results for the second quarter of 2020. As a reminder, the information p

Inogen (INGN) delivered earnings and revenue surprises of 250.00% and -10.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 73.33% over the past year to $0.12, which beat the

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended Ju

Inogen has been a real boom and bust story in terms of its stock price in recent years. The company has seen a steady growth trajectory come to a standstill, with real pressure seen on margins.

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Small-cap medical device company trading at attractive valuations. Leader in portable oxygen concentrators, offering COPD patients mobility.

The Global Medical Oxygen Concentrators Market will grow by USD 1.14 bn during 2020-2024

Wells Fargo & Company MN raised its position in shares of Inogen Inc (NASDAQ:INGN) by 16.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 41,937 shares of the medic

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it

Morgan Stanley raised its stake in Inogen Inc (NASDAQ:INGN) by 99.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest

Janus Henderson Group PLC raised its stake in Inogen Inc (NASDAQ:INGN) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm